Healthcare >> Analyst Interviews >> July 28, 2003

Therapeutics-based Companies: Mark Schoenebaum – U.s. Bancorp Piper Jaffray Inc

MARK J. SCHOENEBAUM is a principal and Senior Research Analyst at U.S. Bancorp Piper Jaffray, focusing on the biotechnology industry. Dr. Schoenebaum joined the firm in January of 2003. Prior to joining the Equity Research department of U.S. Bancorp Piper Jaffray, Dr. Schoenebaum was a senior biotechnology analyst at CIBC World Markets in New York City. Dr. Schoenebaum received a BA with Honors in history and music, summa cum laude, from Indiana University and an MD from the Johns Hopkins University School of Medicine. Profile
TWST: Let's start with a quick overview of your coverage in biotech at

U.S. Bancorp Piper Jaffray.

Mr. Schoenebaum: I cover mainly therapeutics-based companies spanning

all market